Cilfa Opposition, Semaglutide, (Ar114353 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, rosuvastatin, (P000100408)
Countries: Argentina Date: 2002
-
CILFA opposition, benzoilguanidinas (Markush), (P990106043)
Countries: Argentina Date: 2003
-
CILFA opposition, dapagliflozin-empagliflozin-insulin, (AR112015A1)
Countries: Argentina Date: 2019
-
CILFA opposition, trelagliptin, (AR109064A2)
Countries: Argentina Date: 2019
-
CILFA opposition, LIXISENATIDE, (AR103415A1)
Countries: Argentina Date: 2017
-
CILFA opposition, osimertinib, (AR115019A2)
Countries: Argentina Date: 2021
-
CILFA opposition, linaclotide, (AR118601A2)
Countries: Argentina Date: 2021
-
CILFA opposition, cannabidiol, (AR115578A1)
Countries: Argentina Date: 2021
-
CILFA opposition, semaglutide, (AR112480A1)
Countries: Argentina Date: 2020
-
CILFA opposition, pirfenidone , (AR112474A1)
Countries: Argentina Date: 2020